Opinion

Video

Key Efficacy and Safety Takeaways From Recent Data on JAK Inhibitors for MF

Author(s):

Andrew Kuykendall, MD,Raajit K. Rampal, MD, PhD

Drs Rampal and Kuykendall highlight the benefits of pacritinib for patients with low platelet counts, as evidenced by the PERSIST-2 study, and momelotinib for patients with anemia, as shown in the MOMENTUM Phase 3 Study, focusing on their efficacy in spleen volume reduction and symptom relief in patients with myelofibrosis.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All
(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments
Video

(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments

Apr 23rd 2025 - Apr 24th 2026

online-activity
View More
Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2
Video

Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2

Apr 23rd 2025 - Apr 24th 2026

online-activity
View More
Addressing Unmet Needs in HER2+ Metastatic BTC
Video

Addressing Unmet Needs in HER2+ Metastatic BTC

Apr 18th 2025 - Apr 19th 2026

online-activity
View More
Related Content
Acute Lymphoblastic Leukemia | Image Credit: © Nittaya – stock.adobe.com
April 23rd 2025

Inati-Cel Induces High CR and MRD Negativity Rates in CD19+ R/R B-ALL

Chandler Park, MD, medical oncologist, Norton Cancer Institute; Ann S. LaCasce, MD, MMSc, associate professor, medicine, lymphoma specialist, Dana-Farber Cancer Institute, Director, Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology
March 26th 2025

Strong Mentorship Opportunities Support the Next Generations of Women in Lymphoma: With Chandler Park, MD; and Ann S. LaCasce, MD, MMSc

Five Under 5: Top Oncology Videos for the Week of 4/13
April 20th 2025

Five Under 5: Top Oncology Videos for the Week of 4/13

Paul J. Shaughnessy, MD, medical director, Adult Blood and Marrow Stem Cell Transplant Program, Methodist Hospital
November 28th 2024

FDA Approval Insights: Obe-Cel in B-Cell Precursor ALL

Juan Carlos Hernández-Boluda, MD, PhD, an associated physician in the Hematology and Medical Oncology Service at Hospital Clínico of Valencia, Spain
April 18th 2025

An EBMT Machine Learning Model Aids With Transplant Risk Stratification in Myelofibrosis

Dasatinib Plus CAR T-Cell Therapy in Ph+ ALL | Image credit: © Nittaya – stock.adobe.com
April 17th 2025

Dasatinib Plus CAR T-Cell Therapy Shows Efficacy in Ph+ Acute Lymphoblastic Leukemia